Skip to Main Content
Legislation Search

H.R. 4231: Treat and Reduce Obesity Act of 2025

This bill, titled the Treat and Reduce Obesity Act of 2025, aims to address the issue of obesity among Medicare beneficiaries and improve treatment options for this condition, which is linked to numerous health problems and high healthcare costs. Below are the main components of the bill:

Short Title

The legislation is officially referred to as the Treat and Reduce Obesity Act of 2025.

Findings

The bill begins with several findings that highlight the severity of obesity among older adults. Key statistics include:

  • Approximately 41% of adults aged 60 and over were classified as obese as of 2016.
  • Obesity is the second leading cause of death in the U.S., contributing to an estimated 300,000 deaths annually.
  • Obesity leads to increased risks for serious health conditions such as heart disease, diabetes, and high blood pressure.
  • Medicare beneficiaries are increasingly affected by obesity, with a projected significant increase in prevalence by 2030.
  • The economic costs of obesity are substantial, exceeding $427 billion in 2014 alone.

Expansion of Healthcare Provider Eligibility

The bill would allow for a wider range of healthcare providers to offer intensive behavioral therapy for obesity. The following providers would be included:

  • Physicians who are not primarily designated as primary care physicians.
  • Other healthcare professionals such as physician assistants, nurse practitioners, clinical psychologists, and registered dietitians.
  • Community-based lifestyle counseling programs approved by the Secretary of Health and Human Services.

However, therapy provided by these providers must be in coordination with a primary care practitioner, ensuring a comprehensive treatment approach.

Medicare Part D Coverage for Obesity Medication

The bill proposes amendments to expand Medicare Part D coverage to include medications used specifically for the treatment of obesity. This would affect drugs that help manage weight loss for individuals who are overweight or obese and suffer from related health issues.

The coverage adjustments would apply starting two years after the bill’s enactment.

Reporting Requirements

The Secretary of Health and Human Services would be required to submit a report to Congress within one year of the bill's enactment, and every two years thereafter. The report would detail:

  • The steps taken to implement this legislation.
  • Recommendations for improving the coordination of obesity-related programs across federal agencies.

Conclusion

The bill aims to enhance the treatment and prevention of obesity among Medicare beneficiaries by broadening the spectrum of qualified providers and improving medication access, alongside rigorous reporting to ensure effective implementation.

Relevant Companies

None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

55 bill sponsors

Actions

2 actions

Date Action
Jun. 27, 2025 Introduced in House
Jun. 27, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Corporate Lobbying

1 company lobbying

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Marjorie Taylor Greene R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Aug 29, 2025 Aug 28, 2025 -5.49%
Congress pfp
Marjorie Taylor Greene R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $15,001 - $50,000
Aug 20, 2025 Aug 19, 2025 -4.60%
Congress pfp
Scott Franklin R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Aug 14, 2025 Aug 04, 2025 +6.11%
Congress pfp
Lisa C. McClain R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Sale $1,001 - $15,000
Sep 12, 2025 Aug 04, 2025 +6.11%
Congress pfp
Scott Franklin R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Aug 14, 2025 Aug 04, 2025 +6.11%
Congress pfp
Scott Franklin R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Aug 14, 2025 Aug 04, 2025 +6.11%
Congress pfp
Scott Franklin R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $15,001 - $50,000
Aug 14, 2025 Aug 04, 2025 +6.11%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK A S ADR
Sale $50,001 - $100,000
Aug 13, 2025 Jul 30, 2025 +3.95%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK A S ADR
Sale $50,001 - $100,000
Aug 12, 2025 Jul 30, 2025 +3.95%
Congress pfp
Lisa C. McClain R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Sale $1,001 - $15,000
Aug 13, 2025 Jul 10, 2025 -29.60%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Sale $50,001 - $100,000
Jul 07, 2025 Jun 27, 2025 -28.37%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Sale $15,001 - $50,000
Jul 07, 2025 Jun 16, 2025 -39.64%
Congress pfp
Lisa C. McClain R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 09, 2025 -38.74%
Congress pfp
Laurel M. Lee R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Sale $1,001 - $15,000
Jun 22, 2025 May 08, 2025 -33.76%
Congress pfp
Scott Franklin R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Apr 11, 2025 Mar 27, 2025 -39.69%
Congress pfp
Scott Franklin R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $15,001 - $50,000
Apr 11, 2025 Mar 27, 2025 -39.69%
Congress pfp
Byron Donalds R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Sale $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 -48.42%
Congress pfp
Byron Donalds R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Sale $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 -48.42%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Sale $15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 -59.56%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK A S ADR
Sale $50,001 - $100,000
Dec 16, 2024 Nov 19, 2024 -59.56%
Congress pfp
Val T. Hoyle D / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Sep 12, 2025 Oct 29, 2024 -65.66%
Congress pfp
John James R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 -80.22%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Sale $1,001 - $15,000
Sep 16, 2024 Aug 26, 2024 -78.32%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK A S ADR
Purchase $15,001 - $50,000
Sep 16, 2024 Aug 09, 2024 -83.95%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK A S ADR
Purchase $15,001 - $50,000
Sep 16, 2024 Aug 09, 2024 -83.95%
Congress pfp
Ro Khanna D / House
NVO logo
NVO NOVO-NORDISK A/S ADR ADR CMN
Sale $1,001 - $15,000
Aug 07, 2024 Jul 12, 2024 -80.43%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Purchase $15,001 - $50,000
Jun 13, 2024 May 29, 2024 -85.29%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK A S ADR
Purchase $15,001 - $50,000
Jun 13, 2024 May 29, 2024 -85.29%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Purchase $15,001 - $50,000
Jun 13, 2024 May 28, 2024 -84.83%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK A S ADR
Purchase $15,001 - $50,000
Jun 13, 2024 May 06, 2024 -85.02%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Purchase $15,001 - $50,000
Jun 13, 2024 May 06, 2024 -85.02%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Purchase $50,001 - $100,000
May 11, 2024 Apr 24, 2024 -88.39%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Purchase $50,001 - $100,000
May 11, 2024 Apr 24, 2024 -88.39%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Purchase $100,001 - $250,000
May 11, 2024 Apr 23, 2024 -89.13%
Congress pfp
Michael T. McCaul R / House
NVO logo
NVO NOVO NORDISK AS ADR
Purchase $50,001 - $100,000
May 11, 2024 Apr 23, 2024 -89.13%
Congress pfp
Ro Khanna D / House
NVO logo
NVO NOVO-NORDISK A/S ADR ADR CMN
Sale $1,001 - $15,000
Mar 06, 2024 Feb 09, 2024 -87.72%
Congress pfp
Tommy Tuberville R / Senate
NVO logo
NVO Novo Nordisk A/S Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -86.95%
Congress pfp
John James R / House
NVO logo
NVO NOVO NORDISK A/S COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Nov 10, 2023 -97.13%